Metraipolis › archive › dc_1f45f685c48e
Therapeutic drug monitoring of adalimumab in hidradenitis suppurativa: a prospective observational study — Europe PMC PMID:41727443
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41727443
- DOI
- 10.3389/fimmu.2026.1760206
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T02:28:41.842Z
- SHA-256 of the archived text
b8117fa7e7f7ed8ff5d2038a0b59cd3e8f206678b6e43ed2b1a4d3d6323ced54- Stable URL of this page
https://metraipolis.com/documento/dc_1f45f685c48e
How to cite
Therapeutic drug monitoring of adalimumab in hidradenitis suppurativa: a prospective observational study — Europe PMC PMID:41727443 — Europe PMC (en), https://europepmc.org/article/MED/41727443 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1f45f685c48e (Metraipolis archive dc_1f45f685c48e, sha256 b8117fa7e7f7ed8ff5d2038a0b59cd3e8f206678b6e43ed2b1a4d3d6323ced54)
BibTeX
@misc{dc1f45f685c48e,
title = {Therapeutic drug monitoring of adalimumab in hidradenitis suppurativa: a prospective observational study — Europe PMC PMID:41727443},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41727443},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1f45f685c48e; sha256 b8117fa7e7f7ed8ff5d2038a0b59cd3e8f206678b6e43ed2b1a4d3d6323ced54},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41727443. Agents can read the archived copy with the MCP tool read_document.